- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
PD-1 inhibitor Nivolumab prolongs survival in advanced renal cell carcinoma - Commentary
October 1, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
October 1, 2015
Detection of 18F-FDG PET/CT Occult Lesions with 18F-DCFPyL PET/CT in a Patient with Metastatic Renal Cell Carcinoma
September 29, 2015
Role of DNA methylation in renal cell carcinoma
September 28, 2015
Skeletal Muscle Metastasis from Renal Cell Carcinoma: 21 cases and review of the literature
September 25, 2015
Empirical comparison of structure-based pathway methods
September 25, 2015
Renal cell carcinoma: histological classification and correlation with imaging findings
September 25, 2015
Sarcomatoid Renal Cell Carcinoma Metastasis to the Penis
September 24, 2015
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
September 23, 2015
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
September 23, 2015
[Novel biomarkers in renal cell carcinoma : Identification and functional characterization]
September 23, 2015
The Prognostic Impact of a Positive Vascular Margin in pT3 Clear Cell Renal Cell Carcinomas
September 23, 2015
Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs
September 23, 2015
Unusual Malignant Solid Neoplasms of the Kidney: Cross-Sectional Imaging Findings
September 23, 2015
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma.
September 23, 2015
Residual Parenchymal Volume, Not Warm Ischemia Time, Predicts Ultimate Renal Functional Outcomes in Patients Undergoing Partial Nephrectomy
September 22, 2015